Ying, Li
Suyun, Ji
Yanhua, Liang
Yunsheng, Liang
Li, Deng
Lin, Dang
Chengzhi, Lv
Bingjiang, Lin
Furen, Zhang
Wendi, Shi
Jinnan, Li
Yu, Dong
Guanshen, Dou
Shi, Yuling http://orcid.org/0000-0002-1273-7881
Funding for this research was provided by:
Program of Shanghai Academic Research Leader (20XD1403300)
National Natural Science Foundation of China (82073429, 82273510, 82203913)
Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-07-E00046)
Clinical Research Plan of SHDC (SHDC2020CR1014B)
Article History
Received: 13 July 2023
Accepted: 30 August 2023
First Online: 12 October 2023
Declarations
:
: Shi Wendi, Li Jinnan, Dong Yu and Dou Guanshen are employees from Eli Lilly China. Li Ying, Ji Suyun, Liang Yanhua, Liang Yunsheng, Deng Li, Dang Lin, Lv Chengzhi, Lin Bingjiang, Zhang Furen, and Yuling Shi have no conflict of interest to declare.
: The study was conducted in compliance with Good Clinical Practice and the Declaration of Helsinki. The study protocol and its amendments were approved by Independent Ethics Committees at each study center (Table S1). All patients provided written, informed consent prior to participating in the study.